Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inbox Gmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscription Click this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Just For You Momentum Is Just Starting for These 3 Rapid-Growth Stocks in 2026By Nathan Reiff. Originally Published: 2/2/2026. 
In Brief - Corvus Pharmaceuticals has nearly tripled in value this year amid optimism that its atopic dermatitis drug candidate will continue to deliver strong trial results.
- Despite legal and other hurdles, New Era Energy & Digital recently noted a key achievement in its path toward providing data center capacity.
- USA Rare Earth has received around $1.6 billion in federal funding as it seeks to provide a domestic alternative to foreign rare earth minerals.
Nearly one month into 2026, the S&P 500 has been fairly sluggish, rising just over 1% overall after multiple dips throughout January. That middling performance, however, masks the fact that several individual companies have enjoyed a supercharged start to the year and dramatically outperformed the market benchmark. Investors looking to capitalize on rising momentum may consider Corvus Pharmaceuticals Inc. (NASDAQ: CRVS), New Era Energy & Digital Inc. (NASDAQ: NUAI), and USA Rare Earth (NASDAQ: USAR), each of which has returned at least 56% year-to-date (YTD). Analysts Stay Bullish on Corvus With 50%+ Upside Targets After picking Nvidia in 2016, before it jumped 27,000%...
Jeff Brown is back with what he believes will be the biggest paradigm shift ever.
Yes, even bigger than AI. And he found one Seattle company that's at the center of this new $100 trillion revolution.
Click here to get the name of this company, completely free of charge... Click here for the details. As a clinical-stage biopharma company, Corvus sits in an industry prone to rapid, sizable stock swings. A recent catalyst for the stock has been positive data from its drug candidate soquelitinib, being developed to treat atopic dermatitis and other conditions. In mid-January, Corvus reported promising Phase 1 results, including a 72% reduction in eczema severity among patients in the trial. That news helped Corvus shares surge about 188% YTD. A Phase 2 trial is planned for early in the year and could push the stock higher. To fund the upcoming study, Corvus launched a $150 million equity offering that should extend its cash runway, though it carries the usual risk of diluting existing shareholders. The financing is important because Corvus ended the third quarter of 2025 with only $67 million in cash on hand. Analysts remain upbeat: six of seven covering the stock rate CRVS a Buy, and the consensus price target implies roughly 51% upside even after the recent rally. New Era's Data Center Pivot Makes Big Strides, Though Legal and Other Risks Remain New Era & Digital is one of the more polarizing names in the energy exploration and production space in 2026. Shares of NUAI are up more than 114% YTD after the company announced in January a partnership with Primary Digital Infrastructure to deliver up to a gigawatt of data center capacity for hyperscaler clients. That agreement, together with New Era's recent close on a 50% ownership interest in Texas Critical Data Centers, underscores its pivot toward the high-demand data center market. Those moves suggest the company could succeed in its ambitious reorganization. On the other hand, New Era faces legal scrutiny: the Rosen Law Firm has announced plans to investigate allegations of "materially misleading business information." New Era is also relatively small, with a market value just under $400 million, which makes it a higher-risk investment. Still, investors willing to accept those risks may be rewarded if the rally continues. USA Rare Earth Looks to Fill a Significant Supply Chain Need With Government Support Rare-earth minerals are critical for many technologies, and supply-chain and international trade concerns threaten U.S. supplies. USA Rare Earth aims to provide a domestic alternative. The company has been buoyed by a $1.6-billion investment from the federal government and additional private investments in recent weeks, on top of a strong cash position reported with its latest earnings. The firm's rare-earth and magnet production capacity is expanding quickly thanks to operations in Texas, and revenues are expected to grow significantly. For now, however, USA Rare Earth remains an early-stage company without a proven track record of profitability, which may deter some investors. That said, its 56% return so far this year and a strongly optimistic analyst profile suggest it could be positioned for meaningful growth.
| 
No comments:
Post a Comment